Sinovac Biotech Ltd. (sva) - Financial And Strategic Analysis Review --- Aarkstore Enterprise

Sinovac Biotech Ltd

Sinovac Biotech Ltd. (SVA) - Financial and Strategic Analysis Review

Sinovac Biotech Ltd. engages in the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases including hepatitis A, seasonal influenza, H5N1 (bird flu) pandemic influenza and H1N1 influenza. Sinovac was the first company worldwide to receive approval for H1N1 influenza vaccine. In November 2009, the company formed joint venture with Dalian Jingang Group Co., Ltd., to form Sinovac (Dalian) Vaccine Technology Co., Ltd. (Sinovac Dalian), which will be engaged in the research, development, production and commercialization of human-use vaccines.

Sinovac Biotech Ltd. Key Recent Developments

May 13, 2010: Sinovac Reports Net Loss Of $0.3 Million For Q1 2010

Mar 29, 2010: Sinovac Inks Supply, Distribution Agreements With Parenteral Biotech

Feb 16, 2010: Sinovac Expands Production Capacity

Jan 13, 2010: Sinovac Receives Fifth H1N1 Vaccine Order From China

Dec 28, 2009: Sinovac Files Clinical Trial Application For EV 71 With SFDA

This comprehensive SWOT profile of Sinovac Biotech Ltd. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, the highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Sinovac Biotech Ltd., including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

For more information, please visit :

http://www.aarkstore.com/reports/Sinovac-Biotech-Ltd-SVA-Financial-and-Strategic-Analysis-Review-51746.html

by: Aarkstore Enterprise

POST COMMENT

Velcera, Inc. (vlcr) - Financial And Strategic Analysis Review --- Aarkstore Enterprise Viral Genetics, Inc. (vral) - Financial And Strategic Analysis Review --- Aarkstore Enterprise Cordex Pharma, Inc. (cdxp) - Financial And Strategic Analysis Review --- Aarkstore Enterprise Myriad Pharmaceuticals Inc Myrx Financial And Strategic Analysis Review --- Aarkstore Enterprise Wholesale Dvds: Where You Can Get Them Genexine Co., Ltd. (95700) - Financial And Strategic Analysis Review --- Aarkstore Enterprise Aarkstore Enterprise--indoco Remedies Limited (532612) - Financial And Strategic Analysis Review Zhongtian International Limited (2379) - Financial And Strategic Analysis Review --- Aarkstore Giaconda Limited (gia) - Financial And Strategic Analysis Review --- Aarkstore Enterprise Cytodyn, Inc. (cydy) - Financial And Strategic Analysis Review --- Aarkstore Enterprise Intellect Neurosciences, Inc. (ilns) - Financial And Strategic Analysis Review --- Aarkstore Qrxpharma Limited (qrx) - Financial And Strategic Analysis Review --- Aarkstore Enterprise Omeros Corporation (omer) - Financial And Strategic Analysis Review --- Aarkstore Enterprise